ADVANCED HODGKIN LYMPHOMA
Clinical trials for ADVANCED HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ADVANCED HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shorter drug cocktail shows promise for hodgkin lymphoma patients
Disease control Recruiting nowThis study tests a shorter course of a combination of drugs (BrECADD) in people with advanced Hodgkin lymphoma. The goal is to see if this approach can control the disease with fewer side effects. About 48 adults aged 18 to 60 will take part, and researchers will also check if a …
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 26, 2026 11:25 UTC
-
Blood test may allow safer, lighter chemo for hodgkin lymphoma patients
Disease control Recruiting nowThis study is for people with advanced Hodgkin lymphoma (stage 3 or 4) who have not yet had treatment. Researchers are testing whether a blood test that measures tumor DNA can help decide if a person can safely receive fewer chemotherapy cycles than usual. The goal is to reduce s…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Smart scan guides new drug combo in lymphoma trial
Disease control Recruiting nowThis study tests a new treatment for advanced Hodgkin lymphoma that combines the immunotherapy drug nivolumab with chemotherapy. Doctors use PET scans during treatment to see how well it's working and adjust therapy accordingly. The goal is to improve outcomes while reducing side…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Research Center for Hematology, Russia • Aim: Disease control
Last updated May 19, 2026 12:01 UTC